Global Markets for Research Antibodies

Report Scope:

This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF), and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/ biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include North America, Europe, Asia-Pacific, and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

In this report the market for research antibodies is segmented based on product type, major reactivities, applications, and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors, and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on major reactivities, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World (South America, and Middle East and Africa) regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

Report Includes:

- 64 data tables and 25 additional tables
- An overview of the global market for research antibodies
- Estimation of the market size and analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Discussion on the factors affecting the companies market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
- Market share analysis of research antibodies based on product, clonality, application, end-user and region and evaluation of current market trends, market size and forecast
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industrys growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Merck KGaA, Thermo Fisher Scientific, United States Biological, Beckman Coulter Inc., Agilent Technologies Inc. and Cell Signaling Technology
Summary:

The global market for research antibodies was valued at approximately $REDACTED billion in 2019. Among product segments, the primary antibodies segment accounted for the highest market share in the global market for research antibodies in 2019. The primary antibodies segment recorded $REDACTED billion in revenue in 2019, and this segment is expected to grow at a compound annual growth rate (CAGR) of REDACTED% during the forecast period. The high growth rate of this segment is attributed to factors such as demand of antibodies research, the expanding pandemic of COVID-19, other infectious diseases, and anincrease in R&D activities by key companies to emerge with new antibodies to counter the rise indifferent infectious diseases globally. Moreover, the advancement of biological discoveries will result inthe need for more molecular targets to be detected by their antibodies. For example, even for the same protein molecule, antibodies for each of its many forms of post-translational modifications are needed. This is likely to propel the growth of the research antibodies market during the forecast period.

Primary antibodies are used alone or in combination with a secondary antibody. For instance, primary antibodies conjugated to fluorochromes are used in flow cytometry, whereas in microscopy, a primarysecondary antibody combination is used to increase the signal.

According to the Antibiotic.com, one supplier of antibodies states that primary antibodies can be used against any antigen including proteins, peptides, carbohydrates, and other small molecules. Primary antibodies can also be raised to recognize post translational modifications such as phosphorylation, acetylation, methylation, and glycosylation. Hence, the supplier offers more than REDACTED unconjugated and directly conjugated primary antibodies directed against more than REDACTED targets.

The secondary antibodies segment is expected to grow at a compound annual growth rate (CAGR) of REDACTED% during the forecast period. A rise in basic or clinical research to detect specific cell or tissue components (antigens), a shorter assay time, an increase in the versatility, antigen signal detection, and amplification are the factors likely to fuel the growth of the segment in the next few years.

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Emerging Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application
Deals within Last Decade Related to the Research Antibody Industry
WuXi App Tec Acquires Abgent
Abcam Acquires Epitomics
Agilent Acquires Dako
Affymetrix Acquires eBioscience
Bio-Rad Acquires AbD Serotec
Active Motif Acquires SwitchGear Genomics Inc.
Thermo Fisher Pierce Antibodies Merges with Life Technologies Corp.
Fluidigm Acquires DVS Sciences
Bio-Techne (R&D Systems) Acquires Novus Biologicals
Bio-Techne (R&D Systems) Acquires ProteinSimple
BioLegend Acquires Covance Antibody Services
German Merck Acquires Sigma
Abcam Acquires Firefly Bioworks
OriGene Technologies Acquires Acris Antibodies GmbH
Abcam Acquires AxioMx
Valiant Co. Ltd. Acquires MP Biomedicals
Thermo Fisher Scientific Acquires Affymetrix
Aviva Systems Biology Acquires GenWay Biotech
M&A Deals in 2018-2021
LSBio Acquires Absolute Antibody and Kerafast
Eurobio Scientific Acquires Dendritics
ImmunoPrecise Acquires Modiquest Research BV
LSBio Acquisitions in 2020 and 2019
Thermo Fisher Acquires Mesa Biotech
Sanofi to Acquire Kymab
Chapter 4 Research Applications of Antibodies
Introduction
ELISA/ELISPOT
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA
Western Blot
1-D Gel Electrophoresis
2-D Gel Electrophoresis
Emerging Technologies/Platforms in Western Blot
Immunohistochemistry (IHC)
Flow Cytometry (Including Cell Sorting)
Emerging Technologies or Platforms in Flow Cytometry
Immunocytochemistry/Immunofluorescent Staining
Chromatin Immunoprecipitation (ChIP)
Other Applications of Antibodies
Antibody Arrays
Chapter 5 Market Dynamics
Market Drivers
New Discoveries in Biological Sciences
Rapid Technological Developments in the IVD Industry
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Market Restraints
Limited Research Funding
Low Validation Technologies
Decline in Suppliers
Decrease in Market Acceptance or Brand Trust
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Research Antibodies
Chapter 6 Market Breakdown by Product
Global Market for Research Antibodies by Product
Primary Antibodies
Secondary Antibodies
Chapter 7 Market Breakdown by Clonality
Global Market for Research Antibodies by Clonality
Polyclonal Antibodies
Monoclonal Antibodies
Chapter 8 Market Breakdown by Major Reactivities
Global Market for Research Antibodies by Major Reactivities
Human (Anti-Human)
Mouse (Anti-Mouse)
Rat (Anti-Rat)
Chapter 9 Market Breakdown by Application
Global Market for Research Antibodies by Application
Western Blotting (WB)
Flow Cytometry
Immunohistochemistry (IHC)
Immunocytochemistry/Immunofluorescent Staining (ICC/IFS)
ELISA
Chapter 10 Market Breakdown by Host Species
Global Market for Research Antibodies by Host Species
Rabbit Host Species
Goat Host Species
Mouse-Host Species
Sheep Host Species
Donkey Host Species
Other Host Species
Chapter 11 Market Breakdown by End User
Global Market for Research Antibodies by End User
Universities/Academic Institutions
Pharma/Biotech Companies
Other End Users
Chapter 12 Market Breakdown by Region
Global Market for Research Antibodies by Region
North America
Europe
Asia-Pacific
Rest of World
Chapter 13 Impact of COVID-19 on the Pharmaceutical/Biotechnology Industry
Short-term Impacts
Change in Demand
Shift of Communication and Promotions to Remote Interactions
Research and Development Changes
Long-term Impact
Delayed Approvals for Non-COVID-related Pharmaceutical/Biotech Products
Self-sufficiency in Pharma/Biotech Industry
Pharmaceutical Industry Growth Slow-Down
Changes in Consumption Trends in Health-related Products
Chapter 14 Approved Monoclonal Antibodies, 1986-2019
Chapter 15 Value Chain Analysis
Introduction
China Is Becoming a Center of Microbial Threats
Chapter 16 Regulatory Scenario
FDA and International Regulation
Recent Regulatory Reforms
Chapter 17 Competitive Landscape
Global Company Market Ranking Analysis
Antibody Therapeutics Granted in 2018
Chapter 18 Company Profiles
ABCAM
ABSOLUTE ANTIBODY LTD.
AGILENT TECHNOLOGIES INC.
BD BIOSCIENCES
BECKMAN COULTER INC.
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
CELL SIGNALING TECHNOLOGY
JACKSON IMMUNORESEARCH LABORATORIES INC.
MILLIPORESIGMA
ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.
SINO BIOLOGICAL
THERMO FISHER SCIENTIFIC INC.
UNITED STATES BIOLOGICAL
Chapter 19 Appendix: Acronyms

List Of Tables


Summary Table : Global Market for Research Antibodies, by Application, Through 2025
Table 1 : Most-Cited Antibodies and Their Suppliers, 2017
Table 2 : Global Market for Research Antibodies, by Product, Through 2025
Table 3 : Examples of Clinically Important Monoclonal Antibodies
Table 4 : Global Market for Primary Antibodies, by Region, Through 2025
Table 5 : Secondary Antibody Selection
Table 6 : Global Market for Secondary Antibodies, by Region, Through 2025
Table 7 : Global Market for Research Antibodies, by Clonality, Through 2025
Table 8 : Global Market for Polyclonal Antibodies, by Region, Through 2025
Table 9 : Global Market for Monoclonal Antibodies, by Region, Through 2025
Table 10 : Global Market for Research Antibodies, by Major Reactivities, Through 2025
Table 11 : Global Market for Anti-Human Antibodies, by Region, Through 2025
Table 12 : Global Market for Anti-Mouse Research Antibodies, by Region, Through 2025
Table 13 : Rat Antibodies with Different Isotypes.
Table 14 : Global Market for Anti-Rat Research Antibodies, by Region, Through 2025
Table 15 : Global Market for Research Antibodies, by Application, Through 2025
Table 16 : Global Market for Western Blotting Applications, by Region, Through 2025
Table 17 : Global Market for Flow Cytometry Applications, by Region, Through 2025
Table 18 : Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
Table 19 : Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
Table 20 : Global Market for ELISA Applications, by Region, Through 2025
Table 21 : Global Market for Research Antibodies, by Host Species, Through 2025
Table 22 : Global Market for Rabbit Research Antibodies, by Region, Through 2025
Table 23 : Global Market for Goat Research Antibodies, by Region, Through 2025
Table 24 : Global Market for Mouse Research Antibodies, by Region, Through 2025
Table 25 : Global Market for Sheep Research Antibodies, by Region, Through 2025
Table 26 : Global Market for Donkey Research Antibodies, by Region, Through 2025
Table 27 : Global Market for Other Host Species Research Antibodies, by Region, Through 2025
Table 28 : Global Market for Research Antibodies, by End User, Through 2025
Table 29 : Global Market for Research Antibodies in Universities/Academic Institutions, by Region, Through 2025
Table 30 : Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, Through 2025
Table 31 : Global Market for Research Antibodies in Other End Users, by Region, Through 2025
Table 32 : Global Market for Research Antibodies, by Region, Through 2025
Table 33 : U.S. Grants for Research, by Type of Cancer, 2017
Table 34 : North American Market for Research Antibodies, by Product, Through 2025
Table 35 : North American Market for Research Antibodies, by Clonality, Through 2025
Table 36 : North American Market for Research Antibodies, by Major Reactivities, Through 2025
Table 37 : North American Market for Research Antibodies, by Application, Through 2025
Table 38 : North American Market for Research Antibodies, by Host Species, Through 2025
Table 39 : North American Market for Research Antibodies, by End User, Through 2025
Table 40 : North American Market for Research Antibodies, by Country, Through 2025
Table 41 : Estimated New Cancer Cases in Males in Canada, 2017
Table 42 : Estimated New Cancer Cases in Females in Canada, 2017
Table 43 : European Market for Research Antibodies, by Product, Through 2025
Table 44 : European Market for Research Antibodies, by Clonality, Through 2025
Table 45 : European Market for Research Antibodies, by Major Reactivities, Through 2025
Table 46 : European Market for Research Antibodies, by Application, Through 2025
Table 47 : European Market for Research Antibodies, by Host Species, Through 2025
Table 48 : European Market for Research Antibodies, by End Users, Through 2025
Table 49 : European Market for Research Antibodies, by Country, Through 2025
Table 50 : Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, Percent Change 20052016
Table 51 : Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
Table 52 : Asia-Pacific Market for Research Antibodies, by Product, Through 2025
Table 53 : Asia-Pacific Market for Research Antibodies, by Clonality, Through 2025
Table 54 : Asia-Pacific Market for Research Antibodies, by Major Reactivities, Through 2025
Table 55 : Asia Pacific Market for Research Antibodies, by Application, Through 2025
Table 56 : Asia-Pacific Market for Research Antibodies, by Host Species, Through 2025
Table 57 : Asia-Pacific Market for Research Antibodies, by End User, Through 2025
Table 58 : Asia-Pacific Market for Research Antibodies, by Country, Through 2025
Table 59 : Incidence of All Cancers in Australia, by Sex, 2017
Table 60 : Rest of World Market for Research Antibodies, by Product, Through 2025
Table 61 : Rest of World Market for Research Antibodies, by Clonality, Through 2025
Table 62 : Rest of World Market for Research Antibodies, by Major Reactivities, Through 2025
Table 63 : Rest of World Market for Research Antibodies, by Application, Through 2025
Table 64 : Rest of World Market for Research Antibodies, by Host Species, Through 2025
Table 65 : Rest of World Market for Research Antibodies, by End User, Through 2025
Table 66 : Rest of World Market for Research Antibodies, by Country/Region, Through 2025
Table 67 : U.S. FDA-approved Monoclonal Antibodies in the Market
Table 68 : Global Distribution of Antibody Suppliers, by Region, 2018
Table 69 : Distribution of Antibody Suppliers in the U.S., by State, 2017
Table 70 : Antibody Therapeutics Granted First Approvals in The European Union or The United States During, 2018
Table 71 : Abcam: Product Portfolio
Table 72 : Absolute Antibody Ltd.: Product Portfolio
Table 73 : Agilent Technologies Inc.: Product Portfolio
Table 74 : BD Biosciences: Product Portfolio
Table 75 : Beckman Coulter Inc.: Product Portfolio
Table 76 : Bio-Rad: Product Portfolio
Table 77 : Bio-Techne: Product Portfolio
Table 78 : Cell Signaling Technology: Product Portfolio,by Type
Table 79 : Cell Signaling Technology: Products Portfolio, by Source
Table 80 : Jackson ImmunoResearch Laboratories: Product Portfolio
Table 81 : Merck KGaA: Product Portfolio
Table 82 : Rockland Immunochemical Inc.: Product Portfolio
Table 83 : Santa Cruz Biotechnology Inc.: Product Portfolio
Table 84 : Sino Biological: Product Portfolio
Table 85 : Thermo Fisher Scientific: Product Portfolio
Table 86 : United States Biological: Product Portfolio
Table 87 : United States Biological: Product Portfolio
Table 88 : Acronyms Used in this Report

List Of Figures


Summary Figure : Global Market Shares for Research Antibodies, by Application, 2019
Figure 1 : Global Market Shares for Research Antibodies, by Product, 2019
Figure 2 : Global Market Shares for Research Antibodies, by Product, 2025
Figure 3 : Global Market for Primary Antibodies, 20182025
Figure 4 : Global Market for Primary Antibodies, by Region, 20182025
Figure 5 : Global Market for Secondary Antibodies, 20182025
Figure 6 : Global Market for Secondary Antibodies, by Region, 20182025
Figure 7 : Global Market Shares for Research Antibodies, by Clonality, 2019
Figure 8 : Global Market Shares for Research Antibodies, by Clonality, 2025
Figure 9 : Global Market for Polyclonal Antibodies, 20182025
Figure 10 : Global Market for Polyclonal Antibodies, by Region, 20182025
Figure 11 : Global Market for Monoclonal Antibodies, 20182025
Figure 12 : Global Market for Monoclonal Antibodies, by Region, 20182025
Figure 13 : Global Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 14 : Global Market Shares for Research Antibodies, by Major Reactivities, 2025
Figure 15 : Global Market for Anti-Human Research Antibodies, 20182025
Figure 16 : Global Market for Anti-Human Research Antibodies, by Region, 20182025
Figure 17 : Global Market for Anti-Mouse Research Antibodies, 20182025
Figure 18 : Global Market for Anti-Mouse Research Antibodies, by Region, 20182025
Figure 19 : Global Market for Anti-Rat Research Antibodies, 20182025
Figure 20 : Global Market for Anti-Rat Research Antibodies, by Region, 20182025
Figure 21 : Global Market Shares for Research Antibodies, by Application, 2019
Figure 22 : Global Market Shares for Research Antibodies, by Application, 2025
Figure 23 : Global Market for Western Blot Applications, 20182025
Figure 24 : Global Market for Western Blotting Applications, by Region, 20182025
Figure 25 : Global Market for Flow Cytometry Applications, 20182025
Figure 26 : Global Market for Flow Cytometry Applications, by Region, 20182025
Figure 27 : Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 28 : Global Market for Immunohistochemistry (IHC) Applications, 20182025
Figure 29 : Global Market for Immunohistochemistry (IHC) Applications, by Region, 20182025
Figure 30 : Global Market for Immunohistochemistry (IHC) Applications, 20182025
Figure 31 : Global Market for Immunohistochemistry (IHC) Applications, by Region, 20182025
Figure 32 : Global Market for ELISA Applications, 20182025
Figure 33 : Global Market for ELISA Application Segment, by Region, 20182025
Figure 34 : Global Market Shares for Research Antibodies, by Host Species, 2019
Figure 35 : Global Market Shares for Research Antibodies, by Host Species, 2025
Figure 36 : Number of Rabbits used in Research, Testing and Teaching in the U.S., 20122018
Figure 37 : Global Market for Rabbit Research Antibodies, 20182025
Figure 38 : Global Market for Rabbit Research Antibodies, by Region, 20182025
Figure 39 : Global Market for Goat Research Antibodies, 20182025
Figure 40 : Global Market for Goat Research Antibodies, by Region, 20182025
Figure 41 : Global Market for Mouse Research Antibodies, 20182025
Figure 42 : Global Market for Mouse Research Antibodies, by Region, 20182025
Figure 43 : Global Market for Sheep Research Antibodies, 20182025
Figure 44 : Global Market for Sheep Research Antibodies, by Region, 20182025
Figure 45 : Global Market for Donkey Research Antibodies, 20182025
Figure 46 : Global Market for Donkey Research Antibodies, by Region, 20182025
Figure 47 : Global Market for Other Host Species Research Antibodies, 20182025
Figure 48 : Global Market for Other Host Species Research Antibodies, by Region, 20182025
Figure 49 : Global Market Shares for Research Antibodies, by End User, 2019
Figure 50 : Global Market Shares for Research Antibodies, by End User, 2025
Figure 51 : Global Incidence of Patients with Chronic Diseases, 20052030
Figure 52 : Global Market for Research Antibodies in Universities/Academic Institutions, 20182025
Figure 53 : Global Market for Research Antibodies in Universities/Academic Institutions, by Region, 20182025
Figure 54 : Global Market for Research Antibodies in Pharma/Biotech Companies, 20182025
Figure 55 : Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, 20182025
Figure 56 : Global Market for Research Antibodies in Other End Users, 20182025
Figure 57 : Global Market for Research Antibodies in Other End Users, by Region, 20182025
Figure 58 : Global Market Shares for Research Antibodies, by Region, 2019
Figure 59 : Global Market Shares for Research Antibodies, by Region, 2025
Figure 60 : North American Market Shares for Research Antibodies, by Product, 2019
Figure 61 : North American Market Shares for Research Antibodies, by Clonality, 2019
Figure 62 : North American Market Shares for Research Antibodies Market, by Major Reactivities, 2019
Figure 63 : North American Market Shares for Research Antibodies, by Application, 2019
Figure 64 : North American Market Shares for Research Antibodies, by Host Species, 2019
Figure 65 : North American Market Shares for Research Antibodies, by End User, 2019
Figure 66 : North American Market Shares for Research Antibodies, by Country, 2019
Figure 67 : U.S. Market for Research Antibodies, 20182025
Figure 68 : Canadian Market for Research Antibodies, 20182025
Figure 69 : Mexican Market for Research Antibodies, 20182025
Figure 70 : European Market Shares for Research Antibodies, by Product, 2019
Figure 71 : European Market Shares for Research Antibodies, by Clonality, 2019
Figure 72 : European Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 73 : European Market Shares for Research Antibodies, by Application, 2019
Figure 74 : European Market Shares for Research Antibodies, by Host Species, 2019
Figure 75 : European Market Shares for Research Antibodies, by End User, 2019
Figure 76 : European Market Shares for Research Antibodies, by Country, 2019
Figure 77 : German Market for Research Antibodies, 20182025
Figure 78 : French Market for Research Antibodies, 20182025
Figure 79 : Health Spending and Financing in France, 20052018
Figure 80 : Market Demand for Medical Equipment in France, 20152017
Figure 81 : U.K. Market for Research Antibodies, 20182025
Figure 82 : Italian Market for Research Antibodies, 20182025
Figure 83 : Spanish Market for Research Antibodies, 20182025
Figure 84 : Rest of European Market for Research Antibodies, 20182025
Figure 85 : Asia-Pacific Market Shares for Research Antibodies, by Product, 2019
Figure 86 : Asia-Pacific Market Shares for Research Antibodies, by Clonality, 2019
Figure 87 : Asia-Pacific Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 88 : Asia-Pacific Market Shares for Research Antibodies, by Application, 2019
Figure 89 : Asia-Pacific Market Shares for Research Antibodies, by Host Species, 2019
Figure 90 : Asia-Pacific Market Shares for Research Antibodies, by End User, 2019
Figure 91 : Asia-Pacific Market Shares for Research Antibodies, by Country, 2019
Figure 92 : Japanese Market for Research Antibodies, 20182025
Figure 93 : Chinese Market for Research Antibodies, 20182025
Figure 94 : Indian Market for Research Antibodies, 20182025
Figure 95 : Australian and New Zealand Market for Research Antibodies, 20182025
Figure 96 : Rest of Asia-Pacific Market for Research Antibodies, 20182025
Figure 97 : Rest of the World Market Shares for Research Antibodies, by Product, 2019
Figure 98 : Rest of the World Market Shares for Research Antibodies, by Clonality, 2019
Figure 99 : Rest of the World Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 100 : Rest of the World Market Shares for Research Antibodies, by Application, 2019
Figure 101 : Rest of the World Market Shares for Research Antibodies, by Host Species, 2019
Figure 102 : Rest of the World Market Shares for Research Antibodies Major Reactivities, by End User, 2019
Figure 103 : Rest of the World Market Shares for Research Antibodies, by Country/Region, 2019
Figure 104 : Brazilian Market for Research Antibodies, 20182025
Figure 105 : GCC Countries Market for Research Antibodies, 20182025
Figure 106 : Rest of World Countries Market for Research Antibodies, 20182025
Figure 107 : Impact of COVID-19 on the Pharmaceutical/Biotech Industry
Figure 108 : Value Chain Analysis
Figure 109 : Global Market Ranking of Research Antibodies, by Manufacturer, 2019
Figure 110 : Abcam: Annual Revenue, 20182020
Figure 111 : Agilent Technologies Inc.: Annual Revenue, 20162020
Figure 112 : Agilent Technologies Inc.: Revenue Shares, by Region, 2019
Figure 113 : Agilent Technologies Inc.: Revenue Shares, by Business Segments, 2020
Figure 114 : BD Biosciences: Annual Revenue, 20162019
Figure 115 : BD Biosciences: Revenue Shares, by Region, 2019
Figure 116 : BD Biosciences: Revenue Shares, by Business Segments, 2020
Figure 117 : Bio-Rad: Annual Revenue, 20162019
Figure 118 : Bio-Rad: Revenue Shares, by Region, 2019
Figure 119 : Bio-Rad: Revenue Shares, by Business Unit, 2019
Figure 120 : Bio-Techne: Annual Revenue, 20162019
Figure 121 : Bio-Techne: Revenue Shares, by Region, 2019
Figure 122 : Bio-Techne: Revenue Shares, by Business Segment, 2019
Figure 123 : Merck KGaA: Annual Revenue, 20162019
Figure 124 : Merck KGaA: Revenue Shares, by Region, 2019
Figure 125 : Merck KGaA: Revenue Shares, by Investment, 2019
Figure 126 : Thermo Fisher Scientific: Annual Revenue, 20162019
Figure 127 : Thermo Fisher Scientific: Revenue Shares, by Region, 2019
Figure 128 : Thermo Fisher Scientific: Revenue Shares, by Business Segments, 2019

2021 United Therapeutics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Seattle Genetics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

Excipients in Pharmaceuticals: Global Markets to 2026

Report HighlightsThe global market for pharmaceutical excipients should grow from $8.3 billion in 2021 to $10.6 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% for the

USD 5500 View Report

COVID-19 Diagnostics and Kits: Global Markets

Report HighlightsThe global COVID-19 diagnostics market should reach $12.0 billion by 2025 from $10.8 billion in 2020 at a compound annual growth rate (CAGR) of 2.2% for the forecast period

USD 5500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available